Leukemia Research
Volume 33, Issue 11 , Pages 1450-1451, November 2009

Are there new clinical parameters useful to predict response in chronic myeloid leukemia in the imatinib era?

  • Massimo Breccia

      Affiliations

    • Corresponding Author InformationCorresponding author at: Department of Human Biotechnologies and Hematology, Via Benevento 6, 00161 Rome, Italy. Tel.: +39 06 857951; fax: +39 06 44241984.
    • ,
  • Giuliana Alimena

Department of Biotechnologies and Hematology, University “Sapienza”, Rome, Italy

Received 15 June 2009 published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(09)00318-X

doi:10.1016/j.leukres.2009.06.022

Leukemia Research
Volume 33, Issue 11 , Pages 1450-1451, November 2009

Article Tools